🇺🇸 FDA
Pipeline program

Talazoparib

BMNIRN

Phase 1 small_molecule completed

Quick answer

Talazoparib for Childhood Solid Tumors is a Phase 1 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Childhood Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials